Clinical Trial Update: Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss [NA]

View source ↗

Summary

Clinical trial investigating prevention of de novo allosensitization in islet transplant recipients after complete graft loss for Type 1 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: Rodolfo Alejandro | Conditions: Type 1 Diabetes Mellitus | NA | Status: RECRUITING